Skip to main content

Month: September 2021

TILT Holdings Receives Approval to Commence Medical Use of Marijuana Operations for its Brockton, Massachusetts Dispensary, Effective September 21, 2021

Commonwealth Alternative Care’s Brockton dispensary will open its doors on October 1, with a Grand Opening celebration on October 16, 2021 PHOENIX, Sept. 21, 2021 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT or the “Company”) (NEO: TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, today announced that the Massachusetts Cannabis Control Commission (“CCC”) has approved TILT’s subsidiary, Commonwealth Alternative Care, Inc. (“CAC”), to commence retail operations at its forthcoming Brockton dispensary, effective September 21, 2021, for the medical use of marijuana. CAC’s Brockton dispensary is located at 1090 W. Chestnut Street, and operating hours will be from 10 a.m. until 6 p.m., Monday through Sunday....

Continue reading

CSAMT Survey Confirms Low Sulphidation Gold-Silver Mineralizing System at Big Easy, Newfoundland Occurs on a Major Structure That Extends to a Depth of at Least 1 Kilometre

Figure 1Cross Section Showing Combined Resistivity from IP/Res (to 200m) and CSAMT (to 1km depth) on Line 46300N in the Central Anomaly. Locations of previously drilled holes and deeper planned holes are also shown.Figure 2Plan Map of Central Anomaly Target Area showing Location of the CSAMT Lines Surveyed, Location of Figure 1 – Section 46300N and two diamond drill holes (BE-21-37 and -38) completed with assays pending in the current drill program.TORONTO, Sept. 21, 2021 (GLOBE NEWSWIRE) — Cartier Iron Corporation (CSE:CFE) (“Cartier Iron” or the “Company”) is pleased to announce the results of its Controlled Source Audio Magneto-Telluric (“CSAMT”) in the Central Anomaly – Big Easy Showing Area on its 100% owned Big Easy Gold-Silver Project near Clarenville in eastern Newfoundland. CSAMT data...

Continue reading

Lyra Therapeutics Announces Publication of Positive LANTERN Results in the International Forum of Allergy & Rhinology

LYR-210 is the First Drug-Eluting Product Candidate to Demonstrate Statistically Significant Symptom Improvement for Six Months with a Single Administration in Surgically Naïve Chronic Rhinosinusitis Patients Company to Initiate Phase 3 ENLIGHTEN Program around YE’21 WATERTOWN, Mass., Sept. 21, 2021 (GLOBE NEWSWIRE) — Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise, sustained, and local delivery of medications to the ear, nose and throat (ENT) passages and other diseased tissues, today announced that the positive results of the Company’s Phase 2 LANTERN study of LYR-210 were published online in the peer-review journal, International Forum of Allergy & Rhinology. The manuscript titled, “Long-acting implantable corticosteroid matrix for...

Continue reading

Versus Systems, represented by L5 Innovations, Will Power Fan Engagement at 2021 Military Bowl presented by Peraton

Fans of the Military Bowl, at home or in-stadium, will be able to play games, earn points and compete for leaderboard rankings to win prizes LOS ANGELES, Sept. 21, 2021 (GLOBE NEWSWIRE) — Versus Systems Inc. (“Versus” or the “Company”) (Nasdaq: VS) announced today that the company will bring new and unique fan engagement opportunities through its mobile web-based fan engagement and rewards platform to fans of the Military Bowl. The Military Bowl’s experience, powered by Versus Systems, will offer fans the opportunity to engage in exclusive content, trivia, and arcade games for prizes before, during, and after official events. The 2021 Military Bowl presented by Peraton, benefiting the USO will be held December 27, 2021, bringing together teams representing the Atlantic Coast Conference and the American Athletic Conference at Navy-Marine...

Continue reading

Mesa Air Group Announces New Chief Financial Officer

PHOENIX, Sept. 21, 2021 (GLOBE NEWSWIRE) — Mesa Air Group, Inc. (NASDAQ: MESA) Mesa Airlines named Torque Zubeck as its new Chief Financial Officer. Zubeck has been working with Mesa since February as Senior Vice President of Finance. He will be taking over the position of CFO from President Michael Lotz and reporting directly to Chairman and CEO Jonathan Ornstein. Lotz will continue his role as President of Mesa and will be involved in the strategic financial direction, corporate strategies, plans and policies of the company. He will be working closely with Zubeck through the transitional period. “Joining Mesa in March, Torque has quickly proven his value and he has the full confidence of me, the Board and the entire Mesa organization,” said Michael Lotz, Mesa Air Group President. “His background at Alaska Airlines and his focus...

Continue reading

Billy Goat Brands Provides Corporate Update and Investment Outlook

The Venture Capital Platform Announces A New Investment in Evanesce – A Sustainable Packaging Solutions Company VANCOUVER, British Columbia, Sept. 21, 2021 (GLOBE NEWSWIRE) — Billy Goat Brands Ltd. (the “Company” or “Billy Goat”) (CSE: GOAT), a venture capital platform focused on identifying, sponsoring and incubating environmental, social and governance (“ESG”) focused companies in the blue economy, is pleased to provide the following corporate update and investment outlook for Billy Goat’s shareholders, stakeholders and other interested parties. The Company is also pleased to announce its investment in Evanesce Packaging Solutions Inc. (“Evanesce”), which is a sustainable packaging disruptor that is accelerating the adoption of green packaging while re-designing standard disposable food containers. Billy Goat offers investors...

Continue reading

ASLAN Pharmaceuticals Establishes Scientific Advisory Board Chaired by Distinguished Dermatology Expert Dr Lawrence Eichenfield

MENLO PARK. Calif. and SINGAPORE, Sept. 21, 2021 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced the appointment of Dr Lawrence Eichenfield, MD, FAAD, as chair of its Scientific Advisory Board, comprising experts in dermatology and allergic disease from the United States, Canada, Europe, and Asia. Dr Eric Simpson, MD, MCR, was also appointed as a board member. Dr Lawrence Eichenfield is Chief of Pediatric and Adolescent Dermatology at Rady Children’s Hospital-San Diego​, Distinguished Professor of Dermatology and Pediatrics and Vice Chair of the Department of Dermatology at University of California San Diego School of Medicine​. Dr Eichenfield has served as lead author...

Continue reading

SABRE GOLD – 23% Mineral Resource Increase to Gold Ounces At Copperstone, Arizona

TORONTO, Sept. 21, 2021 (GLOBE NEWSWIRE) — Sabre Gold Mines Corp. (TSX: SGLD, OTCQB: SGLDF) (“Sabre Gold” or the “Company”) is pleased to announce an updated mineral resource at its 100%-owned Copperstone gold project located in Arizona, United States. Highlights:23% increase in gold ounces in all categories;53% increase in Measured Resources to 196,000 gold ounces at 7.6 g/t;45% increase in Inferred Resources to 212,000 gold ounces at 5.9 g/t;The resource was estimated at a gold price of $1,700 ounce with a modest reduction of 9,700 ounces when calculated at a gold price of $1,600 ounce;Underground mapping and sampling confirm that the mineralized domains occur where previously modelled;Drilling continued to demonstrate continuity in mineralization within mineralized domains and delimited some domain edges where step...

Continue reading

Clearmind Medicine Partners with The Hebrew University to Develop Novel Psychedelic Drug

The R&D project with Yissum Research Development Company will contribute to Clearmind’s IP portfolio TORONTO, Sept. 21, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Clearmind Medicine Inc. (CSE: CMND) (“Clearmind” or the “Company“), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and undertreated health problems, is pleased to announce it has established a research and development project with Yissum Research Development Company (“Yissum”), the technology transfer company of The Hebrew University of Jerusalem. The collaboration will focus on developing novel, innovative, patentable psychedelics as potential drug candidates to expand Clearmind’s IP portfolio. Yissum is known for its ability to discover, analyze and...

Continue reading

Troilus Drills 4.40 g/t AuEq Over 12 Metres Within a Broader Intersection of 2.10 g/t Over 31 Metres in the J Zone; Confirms +50 Metre Down Dip Mineral Extension

Figure 1Plan View Map of J Zone with Location of New Drill ResultsFigure 2J Zone, Section N15075; View of drill holes TLG-ZJ21-244 and TLG-ZJ21-245TORONTO, Sept. 21, 2021 (GLOBE NEWSWIRE) — Troilus Gold Corp. (TSX: TLG; OTCQX: CHXMF) (“Troilus” or the “Company”) reports additional results from its ongoing exploration and infill drill program on its 100%-owned Troilus Gold Project (“Troilus” or the “Project”), which hosts one of the largest undeveloped gold and copper deposits in Quebec, Canada. New results from the J Zone have further confirmed and expanded a parallel zone of mineralization on the western side of the main ore body by up to 50 metres down dip. This new parallel zone of mineralization can be traced over an 850-metre strike length, and is located primarily within the Preliminary...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.